2nd Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 959, Pharmaceutical Compounding Quality and Accountability Act S. 957, Drug Supply Chain Security Act S.RES.97 : A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Labor Issues/Antitrust/Workplace LBR
S. 504 Fair And Immediate Release of Generic Drugs Act S. 214 Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.